Skip to main content
. 2021 Apr 20;12:677757. doi: 10.3389/fphar.2021.677757

FIGURE 8.

FIGURE 8

Proposed role of HDAC8 in cardiac hypertrophy and fibrosis. Beta-adrenergic agonist isoproterenol increases the expression of HDAC8. Higher levels of HDAC8 induce p38 MAPK phosphorylation and increase the expression of cardiac hypertrophic markers ANP and BNP. PCI34051, a selective inhibitor of HDAC8, retards cardiac hypertrophy and fibrosis by inhibiting p38 MAPK activity.